Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jan 27, 2016
Insider Transaction Report
Form 4
Preti Robert A
See Remarks
Transactions
- Award
Options to Purchase Common Stock
2016-01-25+125,000→ 125,000 totalExercise: $0.63Exp: 2026-01-25→ Common Stock (125,000 underlying) - Award
Common Stock
2016-01-25+76,000→ 270,989 total - Tax Payment
Common Stock
2016-01-25$0.63/sh−7,534$4,746→ 263,455 total
Footnotes (3)
- [F1]Represents 76,000 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. 25% of the shares of restricted stock vest immediately on the grant date and the remaining 75% of the shares of restricted stock will vest quarterly over the following 12 quarters.
- [F2]Includes 57,000 shares of unvested restricted stock.
- [F3]25% of the shares underlying the Options vest immediately on the grant date and the remaining 75% of the shares underlying the Options will vest quarterly over the following 12 quarters.